beta
Trial Radar AI

Showing clinical trials matching location: United States.

I can help you find nearby clinical trials and understand health conditions and treatments.
134 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Location
United States
×
 
Biological Sex
Female
×
 
Intervention
GLP-1
×
 
Study Title
Status
GLP-1 and Hypoglycemia NCT01858896
Active, not recruiting
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805
Not yet recruiting
Assess Impact of Poly-L-lactic Acid on GLP1 Subjects NCT07217743
Not yet recruiting
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Active, not recruiting
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
Recruiting
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) NCT07480109
Not yet recruiting
Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists NCT07221461
Not yet recruiting
Beta-cell Response to Incretin Hormones in Cystic Fibrosis NCT01851694
Recruiting
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists NCT07224880
Recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
Recruiting
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes NCT06967558
Recruiting
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Not yet recruiting
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Active, not recruiting
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans NCT06972407
Not yet recruiting
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse NCT07419854
Recruiting
Effect of Supplement on Appetite and GLP-1 (GLP-1 Suppleme) NCT06790771
Not yet recruiting
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk (SIPPA-QH_HHC-2) NCT07032311
Not yet recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer NCT06751589
Recruiting
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS) NCT07169136
Recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
GLP-1R Actions on Muscle and the Skeleton (GRAMS) NCT07154719
Not yet recruiting
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight (VESPER-1) NCT06712836
Active, not recruiting
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Not yet recruiting
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity (BMT-801) NCT06565611
Active, not recruiting
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500
Recruiting
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619
Recruiting
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes NCT05119179
Recruiting
A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health NCT06911073
Recruiting
Avexitide for Treatment of Post-Bariatric Hypoglycemia (LUCIDITY) NCT06747468
Active, not recruiting
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions NCT06801015
Active, not recruiting
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Recruiting
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance NCT04731272
Recruiting
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH NCT06410924
Active, not recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk (Pre-DM) NCT06446531
Recruiting
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment NCT06411210
Recruiting
Healthy Living BEYOND Weight Study NCT07075341
Recruiting
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide (REMAIN-1) NCT06484114
Active, not recruiting
Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes NCT07210684
Recruiting
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese NCT06732245
Not yet recruiting
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity (PLASTIC) NCT07021937
Not yet recruiting
The Diabetes Staging System in Patient Aligned Care Teams NCT06142006
Recruiting
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder (CRAVE) NCT07218354
Not yet recruiting
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance. (UPGRADE) NCT07224334
Recruiting
Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants NCT07223216
Recruiting
Anti-obesity Pharmacotherapy and Inflammation NCT05756764
Active, not recruiting
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs NCT07437911
Recruiting
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users NCT06467604
Active, not recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy NCT07502508
Recruiting
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome (ZQL008) NCT04575844
Recruiting
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (PLATEAU) NCT07446998
Recruiting